本頁面由Tiger Trade Technology Pte. Ltd.提供服務

enVVeno Medical Corp.

11.70
+0.24002.09%
盤後11.700.00000.00%16:10 EDT
成交量:6,126.00
成交額:7.21萬
市值:765.53萬
市盈率:-0.35
高:12.00
開:11.40
低:11.40
收:11.46
52周最高:196.70
52周最低:8.67
股本:65.43萬
流通股本:50.30萬
量比:1.83
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-33.0600
每股收益(LYR):-33.0600
淨資產收益率:-56.21%
總資產收益率:-35.06%
市淨率:0.28
市盈率(LYR):-0.35

資料載入中...

2021/02/03

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/02/03

SEC問詢函

CORRESP [Cover] - Correspondence
2021/02/03

SEC問詢函

CORRESP [Cover] - Correspondence
2021/01/29

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/28

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/20

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/21

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

重要事件披露

8-K - Current report
2020/12/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/16

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/02

重要事件披露

8-K - Current report
2020/11/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/24

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/11/24

重要事件披露

8-K - Current report
2020/11/17

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/06

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/10/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/15

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/10/08

重要事件披露

8-K - Current report